Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG CLASS:
TAK1 inhibitor
DRUG CLASS:
TAK1 inhibitor
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Related drugs:
‹
NG25 (2)
TL-1-85 (1)
EDHS-206 (1)
NG25 (2)
TL-1-85 (1)
EDHS-206 (1)
›
Associations
(4)
News
Trials
VERI cancer hierarchy
Reset Filters
JAK2 underexpression
Cutaneous Melanoma
JAK2 underexpression
Cutaneous Melanoma
TL-1-85
Sensitive: C3 – Early Trials
TL-1-85
Sensitive
:
C3
TL-1-85
Sensitive: C3 – Early Trials
TL-1-85
Sensitive
:
C3
KRAS mutation
Colorectal Cancer
KRAS mutation
Colorectal Cancer
NG25
Sensitive: D – Preclinical
NG25
Sensitive
:
D
NG25
Sensitive: D – Preclinical
NG25
Sensitive
:
D
NRAS mutation
Melanoma
NRAS mutation
Melanoma
trametinib + EDHS-206
Sensitive: D – Preclinical
trametinib + EDHS-206
Sensitive
:
D
trametinib + EDHS-206
Sensitive: D – Preclinical
trametinib + EDHS-206
Sensitive
:
D
ZNF765 overexpression
Hepatocellular Cancer
ZNF765 overexpression
Hepatocellular Cancer
NG25
Sensitive: D – Preclinical
NG25
Sensitive
:
D
NG25
Sensitive: D – Preclinical
NG25
Sensitive
:
D
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login